Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats (Q44324475)

2 December 2017

title

Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats (English)

1 reference

2 December 2017

1 reference

M Rose

1

1 reference

2 December 2017

B Dudas

series ordinal

2

1 reference

2 December 2017

U Cornelli

series ordinal

3

1 reference

2 December 2017

I Hanin

series ordinal

4

1 reference

2 December 2017

language of work or name

1 reference

1 May 2003

1 reference

2 December 2017

published in

Neurobiology of Aging

1 reference

2 December 2017

volume

24

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

481-490

1 reference

Physostigmine and Recent Memory: Effects in Young and Aged Nonhuman Primates

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Septal lesions, intramaze cues and spatial behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

AF64A (ethylcholine aziridinium ion), a cholinergic neurotoxin, selectively impairs working memory in a multiple component T-maze task.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Glycosaminoglycan polysulfate (Ateroid) in old-age dementias: effects upon depressive symptomatology in geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Sulfated glycosaminoglycans modify growth factor-induced neurite outgrowth in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

AF64A affects septal choline acetyltransferase but not parvalbumin immunoreactive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Reversible cholinergic changes induced by AF64A in rat hippocampus and possible septal compensatory effect

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Effects of AF64A on gene expression of choline acetyltransferase (ChAT) in the septo-hippocampal pathway and striatum in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Central cholinergic correlates of impaired learning

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

The AF64A model of cholinergic hypofunction: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Glycosaminoglycans in nerve injury: 1. Low doses of glycosaminoglycans promote neurite formation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Impairments of learning and memory following intracerebroventricular administration of AF64A in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Septal choline acetyltransferase immunoreactive neurons: dose-dependent effects of AF64A.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Regulation of acetylcholinesterase by nerve growth factor in the pheochromocytoma PC12 cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Atrophy of cholinergic neurons within the rat nucleus basalis magnocellularis following intracortical AF64A infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Inhibition of high affinity choline transport attenuates both cholinergic and non-cholinergic effects of ethylcholine aziridinium (AF64A).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Amyloid beta protein (A beta) removal by neuroglial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Interactions between basic fibroblast growth factor (FGF) and glycosoaminoglycans in promoting neurite outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900093-3

7 January 2021

10.1016/S0197-4580(02)00093-3

Identifiers

DOI

1 reference

2 December 2017

1 reference